Literature DB >> 15975260

Characterisation of protein microheterogeneity and protein complexes using on-chip immunoaffinity purification-mass spectrometry.

Florian J Schweigert1.   

Abstract

Post-translational modification of proteins may influence their interactions with other plasma proteins, as well as having an effect on many aspects of the metabolism of the protein, such as receptor binding, tissue uptake, degradation and excretion. Many post-translational modifications occur in a physiological context, while others are specific for certain diseases, which is why they are of diagnostic importance in clinical proteomics. Analytical approaches to the study of post-translational modifications and protein complexes through the combined use of on-chip immunological affinity purification on a surface-enhanced laser desorption/ionisation platform and subsequent mass spectrometry are illustrated in the author's own work relating to plasma transthyretin (TTR) and retinol-binding protein (RBP). In those studies, both the aspects of post-translational modifications of TTR and the formation of a protein complex between TTR and RBP have been discussed. Such aspects are of diagnostic interest in clinical proteomics, especially with regard to the modification of TTR in relation to the occurrence of amyloidotic diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975260     DOI: 10.1093/bfgp/4.1.7

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  2 in total

1.  Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.

Authors:  Beate Gericke; Jens Raila; Jalid Sehouli; Sophie Haebel; Dominique Könsgen; Alexander Mustea; Florian J Schweigert
Journal:  BMC Cancer       Date:  2005-10-17       Impact factor: 4.430

2.  Analyzing protein micro-heterogeneity in chicken ovalbumin by high-resolution native mass spectrometry exposes qualitatively and semi-quantitatively 59 proteoforms.

Authors:  Yang Yang; Arjan Barendregt; Johannis P Kamerling; Albert J R Heck
Journal:  Anal Chem       Date:  2013-11-22       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.